Penumbra (PEN) Stock Price, News, Quotes-Moomoo

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Insider Sale: CEO and President of $PEN (PEN) Sells 3,281 Shares
Quiver QuantitativeNov 22 20:45 ET
Penumbra(PEN.US) Officer Sells US$3.56 Million in Common Stock
Moomoo NewsNov 22 20:42 ET
Penumbra's Prospective Growth Amidst Market Dynamics Justifies Hold Rating
TipRanksNov 22 06:26 ET · Ratings
3 Reasons Growth Investors Will Love Penumbra (PEN)
Yahoo FinanceNov 21 12:45 ET
Form 144 | Penumbra(PEN.US) Insider Proposes to Sell 7.11 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Nov 20, $Penumbra(PEN.US)$ Insider Adam Elsesser intends to sell 30,000 shares of its common stock on Nov 20, with a total market value of approximately $7.11 million. Adam
Moomoo NewsNov 20 17:48 ET
Penumbra, Inc. to Present at the Piper Sandler 36th Annual Healthcare Conference
PR NewswireNov 20 16:30 ET

Comments

Moomoo AI

Feb 22 11:42

Despite the high P/S ratio, shareholders are holding onto Penumbra's stocks due to its strong future revenue prospects. The strong revenue forecasts are expected to keep the share price buoyant unless the analysts have significantly misjudged the company's potential.

Penumbra, Inc.'s (NYSE:PEN) Earnings Haven't Escaped The Attention Of Investors

Chatterbox Moo

Nov 21, 2023 04:20

Columns Medical-device Stock Selloff Caused by Ozempic Fears Has Gone Too Far—Now They're Rebounding

A new generation of highly effective weight-loss and diabetes drugs known as GLP-1s has led Wall Street to spell doom for companies that have profited from obesity problem. However, the reaction on Wall Street has been extreme, creating opportunities for cooler heads, some analysts and investors say.
To be sure, drugs such as $Novo-Nordisk A/S (NVO.US)$'s Ozempic and Wegovy, and Eli Lilly's Mounjaro have p...

11

Moomoo AI

Nov 9, 2023 05:00

Penumbra's earnings outlook could be brighter than reflected in the statutory profit due to one-off items. The company's profitability this year shows a good sign after previous losses.

The Strong Earnings Posted By Penumbra (NYSE:PEN) Are A Good Indication Of The Strength Of The Business

Moomoo AI

Nov 3, 2023 12:00

Penumbra's low ROE and declining net income over five years hint at sub-par performance. The earnings' decline, despite profit retention, could imply a struggling business or high payout ratio. Analyst estimates, however, foresee a better earnings growth rate.